---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-007083"
form_type: "8-K"
ticker: "EDSA"
cik: "0001540159"
company_name: "Edesa Biotech, Inc."
filed_at: "2024-05-30T23:59:59+00:00"
generated_at: "2026-06-01T07:23:18.935747+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Edesa Biotech shareholders approve 67,000-share increase to equity plan, re-elect all directors

## Summary
- All seven director nominees elected with ~818-819 thousand votes for each; 654k broker non-votes.
- Advisory vote on executive compensation approved: 677,967 for, 122,761 against, 62,400 abstain.
- Plan amendment increasing shares by 67,000 approved: 660,015 for, 151,395 against, 51,718 abstain.
- Approximately 47% of outstanding shares (1,517,529) represented at the meeting.
- MNP LLP appointed as auditors for FY ending Sept 30, 2024 with 1,463,707 votes for.

## SEC filing metadata
- accession: 0001654954-24-007083
- form_type: 8-K
- ticker: EDSA
- cik: 0001540159
- company_name: Edesa Biotech, Inc.
- filed_at: 2024-05-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1540159/000165495424007083/0001654954-24-007083-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1540159/000165495424007083/edsa_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-007083
- JSON: https://secwatch.observer/filing/0001654954-24-007083.json
- Plain text: https://secwatch.observer/filing/0001654954-24-007083.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.